A Phase 1/2 Open-label, Dose-escalation, and Dose-expansion Study of mRNA-4194 in Participants with Lynch Syndrome (INTERCEPT-Lynch)

Principal Investigator

Dr Victoria Woodcock

Contact us

Email: orh-tr.earlyphasenurses@nhs.net

IRAS number

1012429